Nuwellis NUWE
NASDAQ NUWE
$0.80 +0.01 (+1.52%)
At close: Sep 9, 2026 · 4:00 PM EDT

Nuwellis (NUWE) Other Non-Current Liabilities (2015 - 2026)

Nuwellis' (NUWE) quarterly Other Non-Current Liabilities came in at $7.0 million in Q2 2026, down 50.53% on a YoY basis from $14.1 million in Q2 2025, and up 1823.48% quarter-over-quarter from $362000.0 in Q1 2026.

Analysis

Nuwellis (NUWE) Other Non-Current Liabilities (2015 - 2026) Analysis & Trends

Nuwellis (NUWE) has reported Other Non-Current Liabilities for 10 consecutive years, with $7.0 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Other Non-Current Liabilities fell 50.53% year-over-year to $7.0 million; the trailing twelve-month figure through Jun 2026 stood at $7.0 million (down 50.53% YoY), and the FY2025 full-year result was $389000.0, down 16.88% from the prior year.
  • Other Non-Current Liabilities advanced to $7.0 million in Q2 2026 per NUWE's latest filing, from $362000.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $14.1 million in Q2 2025 and bottomed at $71000.0 in Q1 2022.
  • Historically, Other Non-Current Liabilities has averaged $3.3 million across 5 years, with a median of $480000.0 in 2024.
  • The sharpest annual moves came in 2022 and 2024: Other Non-Current Liabilities soared 3736.87% in 2022, then sank 83.54% in 2024.
  • Over 5 years, Other Non-Current Liabilities stood at $6.9 million in 2022, then plunged by 58.61% to $2.8 million in 2023, then tumbled by 83.54% to $468000.0 in 2024, then slipped by 16.88% to $389000.0 in 2025, then soared by 1689.97% to $7.0 million in 2026.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $7.0 million, $362000.0, and $389000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn
10 Nuwellis 140,408.95 -3.78 Mn 1.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.96 Mn
Mar 31, 2026 362,000.00
Dec 31, 2025 389,000.00
Sep 30, 2025 420,000.00
Jun 30, 2025 14.07 Mn
Mar 31, 2025 426,000.00
Dec 31, 2024 468,000.00
Sep 30, 2024 480,000.00
Jun 30, 2024 8.58 Mn
Mar 31, 2024 964,000.00
Dec 31, 2023 2.84 Mn
Dec 31, 2022 6.87 Mn
Mar 31, 2022 71,000.00
Dec 31, 2021 179,000.00
Sep 30, 2021 286,000.00
Sep 30, 2018 126,000.00
Jun 30, 2018 126,000.00
Mar 31, 2018 126,000.00
Dec 31, 2017 126,000.00
Sep 30, 2017 126,000.00